{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:06:23Z","timestamp":1771949183618,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T00:00:00Z","timestamp":1501200000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Development Fund of Medical Research in the Capital, Beijing, China","award":["2014-1-4121"],"award-info":[{"award-number":["2014-1-4121"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00246-017-1683-9","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T03:37:53Z","timestamp":1501213073000},"page":"1450-1455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pediatric Dosing of Intravenous Sotalol Based on Body Surface Area in Patients with Arrhythmia"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1084-8913","authenticated-orcid":false,"given":"Xiaomei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,28]]},"reference":[{"key":"1683_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijcard.2008.04.060","volume":"136","author":"SO Rao","year":"2009","unstructured":"Rao SO, Boramanand NK, Burton DA, Perry JC (2009) Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol. Int J Cardiol 136:253\u2013257","journal-title":"Int J Cardiol"},{"key":"1683_CR2","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1253\/circj.CJ-08-0194","volume":"72","author":"A Miyazaki","year":"2008","unstructured":"Miyazaki A, Ohuchi H, Kurosaki K, Kamakura S, Yagihara T, Yamada O (2008) Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease. Circ J 72:1998\u20132003","journal-title":"Circ J"},{"key":"1683_CR3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00246-011-0010-0","volume":"32","author":"JD Knudson","year":"2011","unstructured":"Knudson JD, Cannon BC, Kim JJ, Moffett BS (2011) High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr Cardiol 32:896\u2013903","journal-title":"Pediatr Cardiol"},{"key":"1683_CR4","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jacc.2005.06.061","volume":"46","author":"S L\u00e4er","year":"2005","unstructured":"L\u00e4er S, Elshoff JP, Meibohm B, Weil J, Mir TS, Zhang W, Hulpke-Wette M (2005) Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia. J Am Coll Cardiol 46:1322\u20131330","journal-title":"J Am Coll Cardiol"},{"key":"1683_CR5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/0735-1097(95)00268-3","volume":"26","author":"JP Pfammatter","year":"1995","unstructured":"Pfammatter JP, Paul T, Lehmann C, Kallfelz HC (1995) Efficacy and proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol 26:1002\u20131007","journal-title":"J Am Coll Cardiol"},{"key":"1683_CR6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-8703(95)90079-9","volume":"130","author":"RE Tanel","year":"1995","unstructured":"Tanel RE, Walsh EP, Lulu JA, Saul JP (1995) Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome. Am Heart J 130:791\u2013797","journal-title":"Am Heart J"},{"key":"1683_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.01.034","author":"X Li","year":"2017","unstructured":"Li X, Zhang Y, Liu H, Jiang H, Ge H, Zhang Y (2017) Efficacy of intravenous sotalol for treatment of incessant tachyarrhythmias in children. Am J Cardiol. doi: 10.1016\/j.amjcard.2017.01.034","journal-title":"Am J Cardiol"},{"key":"1683_CR8","unstructured":"Sotalol hydrochloride injection for intravenous use. US prescribing information. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/022306s000lbl.pdf . Accessed 24 March 2017"},{"key":"1683_CR9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/hrt.54.1.86","volume":"54","author":"TJ Campbell","year":"1985","unstructured":"Campbell TJ, Gavaghan TP, Morgan JJ (1985) Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial. Br Heart J 54:86\u201390","journal-title":"Br Heart J"},{"key":"1683_CR10","first-page":"30","volume":"38","author":"GS Fu","year":"1999","unstructured":"Fu GS, Wille B (1999) Hemodynamic effects and electrophysiological effects of sotalol to patients with fatal ventricular arrhythmia. Chin J Inter Med 38:30\u201332","journal-title":"Chin J Inter Med"},{"key":"1683_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mem.2000.107655","volume":"36","author":"AP Joseph","year":"2000","unstructured":"Joseph AP, Ward MR (2000) A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation. Ann Emerg Med 36:1\u20139","journal-title":"Ann Emerg Med"},{"key":"1683_CR12","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0002-9149(98)00223-9","volume":"81","author":"J Reisinger","year":"1998","unstructured":"Reisinger J, Gatterer E, Heinze G, Wiesinger K, Zeindlhofer E, Gattermeier M, Poelzl G, Kratzer H, Ebner A, Hohenwallner W, Lenz K, Slany J, Kuhn P (1998) Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. Am J Cardiol 81:1450\u20131454","journal-title":"Am J Cardiol"},{"key":"1683_CR13","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1016\/S0002-8703(03)00526-X","volume":"147","author":"SP Thomas","year":"2004","unstructured":"Thomas SP, Guy D, Wallace E, Crampton R, Kijvanit P, Eipper V, Ross DL, Cooper MJ (2004) Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial. Am Heart J 147:E3. doi: 10.1016\/S0002-8703(03)00526-X","journal-title":"Am Heart J"},{"key":"1683_CR14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/hrt.79.6.568","volume":"79","author":"MA Vos","year":"1998","unstructured":"Vos MA, Golitsyn SR, Stangl K, Ruda MY, Van Wijk LV, Harry JD, Perry KT, Touboul P, Steinbeck G, Wellens HJ (1998) Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The ibutilide\/sotalol comparator study group. Heart 79:568\u2013575","journal-title":"Heart"},{"key":"1683_CR15","unstructured":"Sotacor injection prescribing information. http:\/\/www.medsafe.govt.nz\/profs\/Datasheet\/s\/sotacortabinj.pdf . Accessed 24 March 2017"},{"key":"1683_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MJT.0b013e3181ea3184","volume":"17","author":"JC Somberg","year":"2010","unstructured":"Somberg JC, Preston RA, Ranade V, Molnar J (2010) Developing a safe intravenous sotalol dosing regimen. Am J Ther 17:365\u2013372","journal-title":"Am J Ther"},{"key":"1683_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0009-9236(99)70058-5","volume":"66","author":"JT Barbey","year":"1999","unstructured":"Barbey JT, Sale ME, Woosley RL, Shi J, Melikian AP, Hinderling PH (1999) Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects. Clin Pharmacol Ther 66:91\u201399","journal-title":"Clin Pharmacol Ther"},{"key":"1683_CR18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000316050","volume":"116","author":"JC Somberg","year":"2010","unstructured":"Somberg JC, Preston RA, Ranade V, Molnar J (2010) QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. Cardiology 116:219\u2013225","journal-title":"Cardiology"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-017-1683-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-017-1683-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-017-1683-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T15:25:22Z","timestamp":1659281122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-017-1683-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,28]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1007\/s00246-017-1683-9","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,28]]}}}